CoreValve, S.A. Completes $33 Million Private Financing

IRVINE, Calif.--(BUSINESS WIRE)--CoreValve (, a medical device company developing technologies for percutaneous heart valve replacement, announced today that it received $33 million in funding in its third institutional round of financing. Maverick Capital led the round and was joined by existing investors Apax Partners, HealthCap, and Sofinnova Partners.

Back to news